Symposier - Warning on Liver Injury with Propylthiouracil

Links shared publicly online about this topic.

1,003
total visits

Symposier - Warning on Liver Injury with Propylthiouracil

Uploaded and shared in Youtube by: USFoodandDrugAdmin " In a new boxed warning, FDA is reminding healthcare professionals about the risk of serious liver injury, including liver failure and death, from propylthiouracil. This drug, which is used to treat hyperthyroidism, is considered second-line therapy when compared with methimazole, another anti-thyroid drug that poses less risk of liver damage. The new warning highlights that propylthiouracil should be reserved for patients who cannot tolerat

View full resource at symposier.com

Tags: Liver, Liver Condition, Liver Failure, Drug, Healthcare, FDA, Mortality

Most Recently Shared on April 13, 2012 at 4:43 am By:

Symposier Endocrino

Warning on Liver Injury with Propylthiouracil. http://t.co/8HEPPBR3

2 years ago...

Retweet

Favorite

Symposier - Alterations in Lipid Metabolism Mediate Inflammation, Fibrosis, and Proliferation in a Mouse Model of Chronic Cholestatic Liver Injury

symposier.com — “Uploaded and shared in Youtube by: AmerGastroAssn — Dr. Michael Trauner discusses his manuscript "Alterations in Lipid Metabolism Mediate Inflammation, Fibrosis, and Proliferation in a Mouse Model of Chronic Cholestatic Liver Injury." To view the print version of this abstract go to http://bit.ly/s4QzUf.” View full resource at symposier.com